4823 | Jun C, 2020 | 1 | 1 | 3 | | | high risk of bias |
4861 | Cai -FAVIPIRAVIR, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
4899 | ChiCTR2000029826 (Cancelled by the investigator), 0 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
4905 | ChiCTR2000029975, 0 | 2 | 30 | 0 | excluded | not a RCT | risk of bias not avaialble |
4909 | Lee, 2004 | 0 | 1 | 0 | selection pending |
4910 | Soo, 2004 | 0 | 0 | 0 | selection pending |
4911 | HKU/UCH SARS Study Group, 2004 | 0 | 0 | 0 | selection pending |
4912 | Chan, 2003 | 0 | 0 | 0 | selection pending |
4913 | Beigel, 2018 | 0 | 1 | 0 | selection pending |
4980 | jRCTs041190120, 2020 | 1 | 1 | 3 | | | high risk of bias |
4987 | CloroCOVID19, 2020 | 2 | 1 | 3 | excluded | | high risk of bias |
5209 | SIMPLE (Grein), 0 | 2 | 30 | 0 | excluded | not a RCT | risk of bias not avaialble |
5210 | Ye et al., 2020 | 2 | 99 | 0 | excluded | not a RCT | risk of bias not avaialble |
5226 | Duke university (Hydroxychloroquine), 2020 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
5259 | Duke University azithromycin, 2020 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
5288 | Barbosa, 2020 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |
5290 | UAIIC, 2021 | 0 | 1 | 0 | selection pending |
5300 | Raquel, 2019 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
5302 | Peymani, 2016 | 1 | 1 | 3 | | | high risk of bias |
5303 | Jacobson, 2016 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
5307 | CuraChik (De Lamballerie), 2008 | 1 | 1 | 3 | | | high risk of bias |
5308 | Sperber, 1995 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
5309 | Paton, 2012 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
5314 | Magagnoli (HC AZ), 2020 | 1 | 13 | 3 | | not a RCT | high risk of bias |
5351 | Mallat, 2020 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |
5365 | Rosenberg, 2020 | 1 | 13 | 3 | | not a RCT | high risk of bias |
5365 | Rosenberg, 2020 | 1 | 13 | 3 | | not a RCT | high risk of bias |
5365 | Rosenberg, 2020 | 1 | 13 | 3 | | not a RCT | high risk of bias |
5371 | Carlucci, 2020 | 0 | 13 | 4 | selection pending |
5374 | Million, 2020 | 2 | 30 | 0 | excluded | not a RCT | risk of bias not avaialble |
5375 | Mehra, 2020 | 2 | 13 | 3 | excluded | not a RCT | high risk of bias |
5375 | Mehra, 2020 | 2 | 13 | 3 | excluded | not a RCT | high risk of bias |
5416 | Guerin, 2020 | 2 | 31 | 4 | excluded | not a RCT | high risk of bias |
5416 | Guerin, 2020 | 2 | 31 | 4 | excluded | not a RCT | high risk of bias |
5445 | Nguyen, 2020 | 0 | 21 | 0 | selection pending |
5448 | COVID-19 Global Rheumatology Alliance, 2020 | 0 | 13 | 0 | selection pending |
5470 | Singh, 2020 | 0 | 21 | 0 | selection pending |
5471 | Sarayani, 2020 | 0 | 21 | 0 | selection pending |
5482 | Sbidian (HCQ plus AZI), 2020 | 1 | 13 | 4 | | not a RCT | high risk of bias |
5490 | Kurd, 2020 | 0 | 10 | 0 | selection pending |
5509 | Lagier, 2020 | 1 | 13 | 4 | | not a RCT | high risk of bias |
5513 | Arshad (HCQ AZ), 2020 | 1 | 13 | 4 | | not a RCT | high risk of bias |
5521 | Del Amo, 2020 | 2 | 0 | 0 | excluded | | risk of bias not avaialble |
5536 | Ansarin, 2020 | 1 | 1 | 3 | | | high risk of bias |
5546 | remdesevir external control, 0 | 0 | 13 | 0 | selection pending |
5556 | Coenen, 2020 | 0 | 0 | 0 | selection pending |
5559 | Davido, 2020 | 1 | 13 | 4 | | not a RCT | high risk of bias |
5599 | Karolyi, 2020 | 0 | 13 | 0 | selection pending |
5611 | Wang, 0 | 0 | 13 | 0 | selection pending |
5681 | Lane, 2020 | 0 | 13 | 0 | selection pending |
5987 | Duke university HCQ-AZI, 2020 | 1 | 1 | 0 | | | risk of bias not avaialble |
5989 | Yethindra, 2020 | 1 | 1 | 3 | | | high risk of bias |
6031 | NCT04621461, 0 | 0 | 0 | 0 | selection pending |
6034 | Huang, 2020 | 0 | 99 | 0 | selection pending |
6046 | Husain, 2020 | 0 | 1 | 0 | selection pending |
6047 | Hsia, 2020 | 0 | 99 | 0 | selection pending |
6064 | Glorial F, 2020 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
6079 | NCT04422561 (Shouman), 2020 | 1 | 1 | 3 | | | high risk of bias |
6080 | IDEA, 2020 | 2 | 10 | 0 | excluded | not a RCT | risk of bias not avaialble |
6082 | ICON, 2020 | 0 | 13 | 0 | selection pending |
6083 | IFORS (Pott-Junior), 2020 | 2 | 1 | 3 | excluded | | high risk of bias |
6095 | Camprubi, 2020 | 1 | 11 | 0 | | not a RCT | risk of bias not avaialble |
6096 | Elgazzar - treatment, 2020 | 2 | 1 | 3 | excluded | | high risk of bias |
6097 | Elgazzar - prophylaxis, 2020 | 2 | 1 | 3 | excluded | | high risk of bias |
6098 | Patel, 2020 | 2 | 10 | 0 | excluded | not a RCT | risk of bias not avaialble |
6134 | Morgenstern, 2020 | 2 | 30 | 0 | excluded | not a RCT | risk of bias not avaialble |
6184 | Erdem, 2020 | 2 | 11 | 0 | excluded | not a RCT | risk of bias not avaialble |
6244 | Holubar M, 2021 | 1 | 1 | 0 | | | risk of bias not avaialble |
6246 | IRCT20150808023559N20, 0 | 0 | 1 | 0 | selection pending |
6248 | IRCT20151227025726N14 // U07, 0 | 0 | 1 | 0 | selection pending |
6252 | NCT04376814-Group A, 2020 | 0 | 31 | 0 | selection pending |
6255 | IRCT20200428047228N1 // U07, 0 | 0 | 1 | 0 | selection pending |
6262 | Yamamura, 2020 | 2 | 30 | 0 | excluded | not a RCT | risk of bias not avaialble |
6263 | Calik, 2020 | 1 | 10 | 4 | | not a RCT | high risk of bias |
6265 | Shenoy S, 2021 | 1 | 1 | 3 | | | high risk of bias |
6267 | Murohashi, 2020 | 2 | 10 | 0 | excluded | not a RCT | risk of bias not avaialble |
6287 | Kocayigit H, 2020 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
6321 | Podder, 2020 | 1 | 1 | 3 | | | high risk of bias |
6332 | Rodriguez-Molinero, 2020 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
6339 | Delliere, 2020 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |
6368 | Niaee (vs placebo), 2020 | 2 | 1 | 3 | excluded | | high risk of bias |
6369 | Ahmed, 2020 | 1 | 1 | 3 | | | high risk of bias |
6370 | Chachar, 2020 | 1 | 1 | 3 | | | high risk of bias |
6372 | Alam, 2020 | 0 | 31 | 3 | selection pending |
6373 | Behera, 2020 | 1 | 20 | 0 | | not a RCT | risk of bias not avaialble |
6374 | NCT04425850 (Caravallo), 2020 | 2 | 31 | 0 | excluded | not a RCT | risk of bias not avaialble |
6375 | Cadegiani -Iver, 2020 | 2 | 99 | 0 | excluded | not a RCT | risk of bias not avaialble |
6379 | Chamie-Quintero,, 2020 | 2 | 15 | 0 | excluded | not a RCT | risk of bias not avaialble |
6381 | Espitia-Hernandez, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6381 | Espitia-Hernandez, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6381 | Espitia-Hernandez, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6381 | Espitia-Hernandez, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6382 | Khan, 2020 | 0 | 13 | 0 | selection pending |
6382 | Khan, 2020 | 0 | 13 | 0 | selection pending |
6383 | Soto-Becerra, 2020 | 0 | 12 | 2 | selection pending |
6383 | Soto-Becerra, 2020 | 0 | 12 | 2 | selection pending |
6384 | Spoorthi, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6384 | Spoorthi, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6384 | Spoorthi, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6384 | Spoorthi, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6411 | Rocco, 2020 | 1 | 1 | 3 | | | high risk of bias |
6449 | Okumuş, 2020 | 1 | 1 | 3 | | | high risk of bias |
6491 | Ivercar-Tuc, 2021 | 1 | 1 | 3 | | | high risk of bias |
6516 | Eslami, 2020 | 1 | 31 | 0 | | not a RCT | risk of bias not avaialble |
6526 | Dabbous, 2021 | 2 | 1 | 3 | excluded | | high risk of bias |
6575 | Bukhari, 2021 | 1 | 1 | 3 | | | high risk of bias |
6607 | Thomas (zinc only), 2021 | 1 | 1 | 0 | | | risk of bias not avaialble |
6624 | Babalola, 2021 | 1 | 1 | 3 | | | high risk of bias |
6625 | Nasir, 2020 | 2 | 31 | 0 | excluded | not a RCT | risk of bias not avaialble |
6625 | Nasir, 2020 | 2 | 31 | 0 | excluded | not a RCT | risk of bias not avaialble |
6626 | RIVET-COV (Mohan) (12mg and 24mg), 2021 | 1 | 1 | 3 | | | high risk of bias |
6643 | Patel, 2021 | 1 | 0 | 3 | | | high risk of bias |
6675 | Silva, 2021 | 1 | 1 | 3 | | | high risk of bias |
6677 | Mikhaylov, 2021 | 1 | 1 | 0 | | | risk of bias not avaialble |
6703 | Sali, 2021 | 1 | 1 | 3 | | | high risk of bias |
6749 | Chen_oseltamivir, 2020 | 1 | 13 | 4 | | not a RCT | high risk of bias |
6750 | Chen_arbidol, 2020 | 1 | 13 | 4 | | not a RCT | high risk of bias |
6751 | Chen_lopi_rito, 2020 | 1 | 13 | 4 | | not a RCT | high risk of bias |
6767 | Tolouian, 2021 | 1 | 0 | 3 | | | high risk of bias |
6939 | RM08-3008 (Rossignol), 2021 | 1 | 1 | 0 | | | risk of bias not avaialble |
7313 | Abd-Elsalam, 2021 | 1 | 1 | 3 | | | high risk of bias |
7314 | Samaha, 2021 | 2 | 1 | 3 | excluded | | high risk of bias |
7319 | Fontanesi, 2021 | 1 | 1 | 0 | | | risk of bias not avaialble |
7995 | Hazan, 2021 | 2 | 32 | 0 | excluded | not a RCT | risk of bias not avaialble |
8283 | Chahla, 2021 | 1 | 3 | 3 | | | high risk of bias |
8328 | Behera, 2021 | 0 | 13 | 0 | selection pending |
8362 | Winthrop, 2021 | 0 | 1 | 0 | selection pending |
9122 | Ramachandran, 2021 | 0 | 1 | 0 | selection pending |
9127 | Mobarak (DISCOVER), 2021 | 1 | 1 | 0 | | | risk of bias not avaialble |
9262 | EPIC PEP, 2022 | 1 | 1 | 0 | | | risk of bias not avaialble |
9263 | EPIC-SR, 0 | 1 | 1 | 0 | | | risk of bias not avaialble |
9462 | Mayer, 2022 | 0 | 0 | 0 | selection pending |
9976 | ANTICOV, 0 | 0 | 0 | 0 | selection pending |
10322 | Elgazzar, 0 | 2 | 0 | 0 | excluded | | risk of bias not avaialble |
10323 | Seet 2021, 2021 | 1 | 1 | 3 | | | high risk of bias |